About Wing Tech

Founded in 2004, Wing Tech brings more than two decades of experience supporting a diverse client base, including Fortune 500 medical technology companies, leading research institutions, investors, and emerging life sciences ventures.

The firm combines advanced quantitative modeling and decision-analysis methodologies with extensive clinical, technical, and industry expertise. Working closely with clients and research collaborators, Wing Tech develops rigorous, evidence-based analyses to inform decisions throughout the health technology lifecycle—from early-stage opportunity assessment and product development to clinical evaluation, market access, and commercialization.

Wing Tech’s approach emphasizes the systematic assessment of clinical and economic value, uncertainty, and strategic opportunities. The firm’s analytical frameworks help clients:

Identify the clinical, economic, and market factors most critical to product success.
Characterize and quantify uncertainties associated with emerging technologies and their applications.
Evaluate alternative development and commercialization scenarios to inform strategic decisions.

Leadership

Wing Tech's leadership team and advisors bring extensive experience in medical technology innovation, health economics, evidence development, and strategic planning. Their multidisciplinary backgrounds combine scientific and analytical expertise with a comprehensive understanding of the challenges facing established and emerging life sciences companies.

Strategic Locations

With offices in the United States and Germany (Wingtec GmbH), Wing Tech maintains a presence near leading centers of medical technology innovation, healthcare policy, and regulatory decision-making, including Silicon Valley, Southern California, Washington, DC, and Switzerland.